mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
AZD6482 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
SR1001 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
BRD-K03911514 |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.7 |
mRNA |
BRD-M00053801 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.7 |
mRNA |
N9-isopropylolomoucine |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |